CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Swedish Orphan Biovitrum AB (publ) Company Snapshot
Swedish Orphan Biovitrum AB (publ) operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Swedish Orphan Biovitrum AB (publ) with three other pharmaceutical manufacturers in Europe: Recipharm AB (publ) (2016 sales of 4.68 billion Swedish Kronor [US$577.72 million] of which 43% was MS-SO), Sopharma AD of Bulgaria (885.38 million Bulgarian Lev [US$536.92 million] of which 51% was Tablets), and BTG Plc which is based in the United Kingdom (£447.50 million [US$595.87 million] of which 37% was Licensing).

Sales Analysis. Swedish Orphan Biovitrum AB (publ) reported sales of SEK 4.50 billion (US$555.25 million) for the year ending December of 2016. This represents an increase of 39.3% versus 2015, when the company's sales were SEK 3.23 billion. Sales at Swedish Orphan Biovitrum AB (publ) have increased during each of the previous five years (and since 2011, sales have increased a total of 135%). Sales of Core Products/kineret saw an increase of 24.3% in 2016, from SEK 805.36 million to SEK 1.00 billion. Not all segments of Swedish Orphan Biovitrum AB (publ) experienced an increase in sales in 2016: sales of Royalty-Refacto fell 43.6% to SEK 88.00 million. (However, this segment's sales were only a very small portion of the company's overall sales). Swedish Orphan Biovitrum AB (publ) also experienced decreases in sales in Core Products/orfadin (down 3.2% to SEK 770.00 million) and Other Core Products (down 26.9% to SEK 105.00 million) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Swedish Orphan Biovitrum AB (publ)
  Stock Performance Chart for Swedish Orphan Biovitrum AB (publ)
 
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): 119.30
(Figures in Swedish Kronor)
1 Week -4.9%   13 Weeks -1.7%  
4 Weeks -4.9%   52 Weeks 17.7%  
 
Swedish Orphan Biovitrum AB (publ) Key Data:
  Ticker: SOBI Country: Sweden
  Exchanges: FRA LON STO OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 4,496,340,000
(Year Ending Jan 2017).
Employees: 760
  Currency: Swedish Kronor Market Cap: 32,106,489,502
  Fiscal Yr Ends: December Shares Outstanding: 269,123,969
  Share Type: Aktie Closely Held Shares: 2,992,120
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.